42835-47-2

Basic information

• Product Name: ethyl 9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylate
• Synonyms: ethyl 9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylate;IVK/4022171
• CAS NO: 42835-47-2
• Molecular Formula: C₁₆H₁₆FNO₃
• Molecular Weight: 289.3015432
• Mol File: 42835-47-2.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ethyl 9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylate(42835-47-2)
• EPA Substance Registry System: ethyl 9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylate(42835-47-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 42835-47-2(Hazardous Substances Data)

Usage

Uses

Flumequine Ethyl Ester is an impurity of Flumequine (F445000), a quinolone antibacterial.

Upstream product

• 1128-61-6 6-fluoro-2-methyl-quinoline 
• 105450-09-7 Diethyl (2-methyl-6-fluorotetrahydro-quinolin-1-yl)methylenemalonate 
• 42835-25-6 flumequine 
• 75-03-6 ethyl iodide 
• 87-13-8 diethyl 2-ethoxymethylenemalonate 
• 42835-89-2 6-fluoro-1,2,3,4-tetrahydro-2-methylquinoline 

Downstream Products

• 42835-73-4 9-Fluor-6,7-dihydro-5-methyl-1-oxo-1H,5H-benzochinolizin-2-carbonsaeurehydrazid 
• 42835-25-6 flumequine 

Relevant articles and documents

Selective Catalytic Hydrogenation of Heteroarenes with N-Graphene-Modified Cobalt Nanoparticles (Co3O4-Co/NGratα-Al2O3)

Cobalt oxide/cobalt-based nanoparticles featuring a core-shell structure and nitrogen-doped graphene layers on alumina are obtained by pyrolysis of Co(OAc)2/phenanthroline. The resulting core-shell material (Co3O4-Co/NGratα-Al2O3) was successfully applied in the catalytic hydrogenation of a variety of N-heteroarenes including quinolines, acridines, benzo[h], and 1,5-naphthyridine as well as unprotected indoles. The peculiar structure of the novel heterogeneous catalyst enables activation of molecular hydrogen at comparably low temperature. Both high activity and selectivity were achieved in these hydrogenation processes, to give important building blocks for bioactive compounds as well as the pharmaceutical industry.

MACROLONE COMPOUNDS

A compound of formula (I) compositions comprising same, processes for their preparation and use of said compounds, particularly in the treatment of microbial infections.